Pfizer has entered into a research collaboration with Insilico Medicine to utilize Insilico’s machine learning technology and Pandomics Discovery Platform with the goal of identifying real-world evidence for potential therapeutic targets implicated in a variety of diseases. “Insilico is advancing its latest target identification systems utilizing machine learning, generative biology methods, and synthetic data generation pipelines, and we are pleased to be collaborating with Pfize...